DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic Cancer
Condition(s):Pancreatic CancerLast Updated:November 3, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Pancreatic CancerLast Updated:November 3, 2022Recruiting
Condition(s):Metastatic and/or High Risk Solid Tumor of ChildrenLast Updated:January 31, 2024Completed
Condition(s):Anterior Cutaneous Nerve Entrapment Syndrome; Nerve Entrapment Syndrome; Chronic Pain SyndromeLast Updated:October 30, 2023Recruiting
Condition(s):Metastatic Breast CancerLast Updated:July 30, 2020Completed
Condition(s):Recurrent Cervical Cancer; Nucleotide Variant; Copy Number Variation; Insertion-deletion Variation; Genomic Structural Variation; Total Mutation Burden; Microsatellite Instability; PD-1; PD-L1Last Updated:December 20, 2019Unknown status
Condition(s):Epithelial Ovarian Cancer; Nucleotide Variant; Copy Number Variation; Insertion-deletion Variation; Genomic Structural Variation; Total Mutation Burden; Microsatellite Instability; PD-1; PD-L1Last Updated:December 20, 2019Unknown status
Condition(s):PhotoagingLast Updated:October 15, 2021Unknown status
Condition(s):Chronic Myeloid Leukaemia Recurrent; Chronic Myeloid Leukemia, in RelapseLast Updated:October 18, 2021Unknown status
Condition(s):Locally Advanced or Metastatic EGFR(+) NSCLC PatientsLast Updated:June 12, 2019Completed
Condition(s):Waldenstrom’s DiseaseLast Updated:July 30, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.